Viara Research
Laboratory supply · Viara group
Viara Labs
Viara Research laboratory reference material: Tesamorelin 10 mg, Retatrutide 10 mg and BPC-157 10 mg lyophilised vials, purity at or above 99 percent by HPLC, certificate of analysis per lot. For research use only. Not for human or veterinary consumption. Supplied to institutions against a stated research use.
Viara Research Retatrutide laboratory reference material, 10 mg lyophilised vial, purity at or above 99 percent by HPLC. For research use only. Not for human or veterinary consumption. Supplied to institutions against a stated research use.
Product catalog Viara Labs
9 compounds
Swipe for the range 1 / 9
Viara Research Retatrutide vial, 10 mg lyophilised, labelled for research use only

Retatrutide

Investigational triple agonist at the GIP, GLP-1 and glucagon receptors. Approved nowhere; supplied on enquiry only.

$99 per 10 mg vial
SKU
VR-RETA-10
Format
10 mg lyophilised
Purity
≥ 99% (HPLC)
Note
Unapproved investigational agent
Viara Research BPC-157 vial, 5 mg lyophilised, labelled for research use only

BPC-157

Pentadecapeptide matching a fragment of a protein found in gastric juice.

$49 per 5 mg vial
SKU
VR-BPC157-5
Format
5 mg lyophilised
Purity
≥ 99% (HPLC)
Viara Research TB-500 vial, 10 mg lyophilised, labelled for research use only

TB-500

Synthetic fragment corresponding to the actin-binding region of thymosin β4.

$79 per 10 mg vial
SKU
VR-TB500-10
Format
10 mg lyophilised
Purity
≥ 99% (HPLC)
Note
Category 2 — not compoundable
Viara Research BPC-157 / TB-500 vial, 5 mg / 5 mg lyophilised, labelled for research use only

BPC-157 / TB-500

Two-component blend: the pentadecapeptide BPC-157 alongside TB-500.

$89 per 10 mg vial
SKU
VR-BPCTB-5-5
Format
5 mg / 5 mg lyophilised
Purity
≥ 99% (HPLC)
Composition
Stated on COA
Viara Research CJC-1295 w/ DAC + Ipamorelin vial, 5 mg / 5 mg lyophilised, labelled for research use only

CJC-1295 w/ DAC + Ipamorelin

Two-component blend pairing the GRF(1–29) analogue with the pentapeptide ipamorelin.

$110 per 10 mg vial
SKU
VR-CJCIPA-5-5
Format
5 mg / 5 mg lyophilised
Purity
≥ 99% (HPLC)
Composition
Stated on COA
Viara Research Tesamorelin vial, 10 mg lyophilised, labelled for research use only

Tesamorelin

Forty-four residue analogue of growth hormone-releasing hormone, acylated at the N-terminus.

$109 per 10 mg vial
SKU
VR-TESA-10
Format
10 mg lyophilised
Purity
≥ 99% (HPLC)
Note
Approved form exists
Viara Research MOTS-c vial, 10 mg lyophilised, labelled for research use only

MOTS-c

Sixteen residues, encoded in the mitochondrial genome rather than the nuclear one.

$69 per 10 mg vial
SKU
VR-MOTSC-10
Format
10 mg lyophilised
Purity
≥ 99% (HPLC)
Viara Research Semax vial, 10 mg lyophilised, labelled for research use only

Semax

Seven residues. An analogue of the ACTH(4–7) fragment, extended with Pro-Gly-Pro so it resists enzymatic cleavage.

$59 per 10 mg vial
SKU
VR-SEMAX-10
Format
10 mg lyophilised
Purity
≥ 99% (HPLC)
Note
No approved US form
Viara Research Selank vial, 10 mg lyophilised, labelled for research use only

Selank

Seven residues. An analogue of tuftsin, the immunomodulatory tetrapeptide, carrying the same Pro-Gly-Pro extension.

$59 per 10 mg vial
SKU
VR-SELANK-10
Format
10 mg lyophilised
Purity
≥ 99% (HPLC)
Note
No approved US form
Regulatory

Where each compound actually stands.

Two things moved this year and most of our category has not updated its copy. Removal from Category 2 is not permission to compound, and an advisory vote is not a rule. Both matter if you are planning around availability.

CompoundApril 2026July 2026 — PCACCompoundable today
RetatrutideNot applicableNot applicableNo — unapproved drug
BPC-157Off Category 2Recommended, 8–6–1No — rulemaking pending
TB-500Category 2Not reviewedNo — Category 2
BPC-157 / TB-500BPC-157 off Category 2; TB-500 in Category 2BPC-157 recommended, 8–6–1No — TB-500 in Category 2
CJC-1295 + IpamorelinCJC-1295 in Category 2; ipamorelin off Category 2Not reviewedNo — CJC-1295 in Category 2
TesamorelinNot in this groupNot reviewedApproved form exists — EGRIFTA
MOTS-cOff Category 2Recommended, 7–5–2No — rulemaking pending
SemaxNot in this groupNot reviewedNo — unapproved drug
SelankNot in this groupNot reviewedNo — unapproved drug
Eligibility

Who we can supply, and who we cannot.

Who this is for

  • Academic and institutional laboratories
  • Commercial R&D and contract research organisations
  • Analytical labs needing reference material
  • Buyers who can state an in-vitro or preclinical use

Who this is not for

  • Individuals buying for personal use
  • Clinics or prescribers sourcing patient material
  • Anyone intending human or veterinary administration
  • Resale into consumer channels
Documentation

What you get, and what to ask for.

Certificate of analysis

Requested, not enclosed. Certificates are not shipped with the vial — ask for one by lot number, before or after purchase, and we issue it for that lot. Identity, purity by HPLC and the analytical detail your records need, tied to the lot in front of you rather than a representative run.

Batch code and fill date

Printed at fill, so any vial traces back to its production run. If a lot is ever withdrawn you can tell in seconds whether you hold it.

Handling and storage

Lyophilised, shipped ambient, with reconstitution and storage guidance for laboratory conditions. Cold chain available on request for longer transit.